JFS Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

JFS Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10	Hold	1	–	–	﹤0.01%	2250
2026 Q1	$7	Buy	+1	New	+$8	﹤0.01%	1884

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

JFS Wealth Advisors's DNA Position: Q2 2026 in Review

JFS Wealth Advisors held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 1 share worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

JFS Wealth Advisors first reported a position in DNA in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

JFS Wealth Advisors held 1 share of Ginkgo Bioworks worth $10 as of Q2 2026.
JFS Wealth Advisors left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #2250 holding.
JFS Wealth Advisors first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 2 quarters since.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.